247 related articles for article (PubMed ID: 25896309)
1. Gout after living kidney donation: correlations with demographic traits and renal complications.
Lam NN; Garg AX; Segev DL; Schnitzler MA; Xiao H; Axelrod D; Brennan DC; Kasiske BL; Tuttle-Newhall JE; Lentine KL
Am J Nephrol; 2015; 41(3):231-40. PubMed ID: 25896309
[TBL] [Abstract][Full Text] [Related]
2. Race, Relationship and Renal Diagnoses After Living Kidney Donation.
Lentine KL; Schnitzler MA; Garg AX; Xiao H; Axelrod D; Tuttle-Newhall JE; Brennan DC; Segev DL
Transplantation; 2015 Aug; 99(8):1723-9. PubMed ID: 25905980
[TBL] [Abstract][Full Text] [Related]
3. Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.
Lentine KL; Schnitzler MA; Garg AX; Xiao H; Axelrod D; Tuttle-Newhall JE; Brennan DC; Segev DL
Am J Nephrol; 2014; 40(2):174-83. PubMed ID: 25196154
[TBL] [Abstract][Full Text] [Related]
4. Racial variation in medical outcomes among living kidney donors.
Lentine KL; Schnitzler MA; Xiao H; Saab G; Salvalaggio PR; Axelrod D; Davis CL; Abbott KC; Brennan DC
N Engl J Med; 2010 Aug; 363(8):724-32. PubMed ID: 20818874
[TBL] [Abstract][Full Text] [Related]
5. Hospitalizations following living donor nephrectomy in the United States.
Schold JD; Goldfarb DA; Buccini LD; Rodrigue JR; Mandelbrot D; Heaphy EL; Fatica RA; Poggio ED
Clin J Am Soc Nephrol; 2014 Feb; 9(2):355-65. PubMed ID: 24458071
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in use of prescription narcotic medications among living kidney donors.
Lentine KL; Lam NN; Schnitzler MA; Garg AX; Xiao H; Leander SE; Brennan DC; Taler SJ; Axelrod D; Segev DL
Clin Transplant; 2015 Oct; 29(10):927-37. PubMed ID: 26227016
[TBL] [Abstract][Full Text] [Related]
7. Obesity increases the risk of end-stage renal disease among living kidney donors.
Locke JE; Reed RD; Massie A; MacLennan PA; Sawinski D; Kumar V; Mehta S; Mannon RB; Gaston R; Lewis CE; Segev DL
Kidney Int; 2017 Mar; 91(3):699-703. PubMed ID: 28041626
[TBL] [Abstract][Full Text] [Related]
8. Health outcomes among non-Caucasian living kidney donors: knowns and unknowns.
Lentine KL; Segev DL
Transpl Int; 2013 Sep; 26(9):853-64. PubMed ID: 23531054
[TBL] [Abstract][Full Text] [Related]
9. Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors.
Lentine KL; Schnitzler MA; Xiao H; Axelrod D; Garg AX; Tuttle-Newhall JE; Brennan DC; Segev DL
Transplantation; 2014 Feb; 97(3):316-24. PubMed ID: 24192712
[TBL] [Abstract][Full Text] [Related]
10. Gout after living kidney donation: a matched cohort study.
Lam NN; McArthur E; Kim SJ; Prasad GV; Lentine KL; Reese PP; Kasiske BL; Lok CE; Feldman LS; Garg AX; ;
Am J Kidney Dis; 2015 Jun; 65(6):925-32. PubMed ID: 25818677
[TBL] [Abstract][Full Text] [Related]
11. Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.
Serrano OK; Sengupta B; Bangdiwala A; Vock DM; Dunn TB; Finger EB; Pruett TL; Matas AJ; Kandaswamy R
Surgery; 2018 Nov; 164(5):1071-1076. PubMed ID: 30149934
[TBL] [Abstract][Full Text] [Related]
12. Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.
Lentine KL; Schnitzler MA; Xiao H; Axelrod D; Davis CL; McCabe M; Brennan DC; Leander S; Garg AX; Waterman AD
Transplantation; 2012 Jul; 94(1):77-83. PubMed ID: 22691958
[TBL] [Abstract][Full Text] [Related]
13. Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.
Lentine KL; Koraishy FM; Sarabu N; Naik AS; Lam NN; Garg AX; Axelrod D; Zhang Z; Hess GP; Kasiske BL; Segev DL; Henderson ML; Massie AB; Holscher CM; Schnitzler MA
Clin Transplant; 2019 Oct; 33(10):e13696. PubMed ID: 31421057
[TBL] [Abstract][Full Text] [Related]
14. Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.
Holscher CM; Bae S; Thomas AG; Henderson ML; Haugen CE; DiBrito SR; Muzaale AD; Garonzik Wang JM; Massie AB; Lentine KL; Segev DL
Transplantation; 2019 Jun; 103(6):1216-1223. PubMed ID: 30247449
[TBL] [Abstract][Full Text] [Related]
15. Risks and outcomes of living donation.
Lentine KL; Patel A
Adv Chronic Kidney Dis; 2012 Jul; 19(4):220-8. PubMed ID: 22732041
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of kidney donation on renal function and blood pressure in African Americans.
Budisavljevic MN; Nietert PJ; Zhai Y; Dooley MJ; Rajagopalan PR
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1474-80. PubMed ID: 21551019
[TBL] [Abstract][Full Text] [Related]
17. Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.
Lentine KL; Vijayan A; Xiao H; Schnitzler MA; Davis CL; Garg AX; Axelrod D; Abbott KC; Brennan DC
Transplantation; 2012 Jul; 94(2):139-44. PubMed ID: 22825543
[TBL] [Abstract][Full Text] [Related]
18. Obesity and long-term mortality risk among living kidney donors.
Locke JE; Reed RD; Massie AB; MacLennan PA; Sawinski D; Kumar V; Snyder JJ; Carter AJ; Shelton BA; Mustian MN; Lewis CE; Segev DL
Surgery; 2019 Aug; 166(2):205-208. PubMed ID: 31072668
[TBL] [Abstract][Full Text] [Related]
19. Risk of ESRD in prior living kidney donors.
Wainright JL; Robinson AM; Wilk AR; Klassen DK; Cherikh WS; Stewart DE
Am J Transplant; 2018 May; 18(5):1129-1139. PubMed ID: 29392849
[TBL] [Abstract][Full Text] [Related]
20. Health insurance status of US living kidney donors.
Gibney EM; Doshi MD; Hartmann EL; Parikh CR; Garg AX
Clin J Am Soc Nephrol; 2010 May; 5(5):912-6. PubMed ID: 20413444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
